SAS Health: Cohort Builder Discussions

Health care researchers and regulatory agencies need a more comprehensive view of individuals and populations to make confident decisions about health care and policy. But clinical trial data, electronic health records, claims data and adverse-event reports are only snapshots of patients at random points in time. To provide real value, a holistic patient profile is necessary to achieve the greatest eŽect on health and wellness. When users leave SAS Health: Cohort Builder reviews, G2 also collects common questions about the day-to-day use of SAS Health: Cohort Builder. These questions are then answered by our community of 850k professionals. Submit your question below and join in on the G2 Discussion.